Related references
Note: Only part of the references are listed.Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1re/e mice further supports a modulating role for melanocortins in collagen synthesis of the skin
Markus Boehm et al.
EXPERIMENTAL DERMATOLOGY (2014)
Genetic Ablation of Mast Cells Redefines the Role of Mast Cells in Skin Wound Healing and Bleomycin-Induced Fibrosis
Sebastian Willenborg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Interleukin-17A+Cell Counts Are Increased in Systemic Sclerosis Skin and Their Number Is Inversely Correlated With the Extent of Skin Involvement
Marie-Elise Truchetet et al.
ARTHRITIS AND RHEUMATISM (2013)
Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1
Shiro Ohgo et al.
EXPERIMENTAL DERMATOLOGY (2013)
Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
Akira Tokumura et al.
International Journal of Medical Sciences (2012)
T cells in systemic sclerosis: a reappraisal
Steven O'Reilly et al.
RHEUMATOLOGY (2012)
Amelioration of Dermal Fibrosis by Genetic Deletion or Pharmacologic Antagonism of Lysophosphatidic Acid Receptor 1 in a Mouse Model of Scleroderma
Flavia V. Castelino et al.
ARTHRITIS AND RHEUMATISM (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway
Claudio Cabello-Verrugio et al.
CELLULAR SIGNALLING (2011)
Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
Zhaohong Yin et al.
RHEUMATOLOGY (2010)
Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet Activation
Jesica R. Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lysophosphatidic acid and renal fibrosis
Jean-Philippe Pradere et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew M. Tager et al.
NATURE MEDICINE (2008)
LPA1 receptor activation promotes renal interstitial fibrosis
Jean-Philippe Pradere et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity
Naoko Watanabe et al.
LIFE SCIENCES (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells
Rongbing Chen et al.
STEM CELLS AND DEVELOPMENT (2006)
Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis
Eugene Y. Kissin et al.
ARTHRITIS AND RHEUMATISM (2006)
The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
T Yamamoto
ARCHIVES OF DERMATOLOGICAL RESEARCH (2006)
Lysophosphatidic acid (LPA) induces plasma exudation and histamine release in mice via LPA receptors
T Hashimoto et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Chemokines and chemokine receptors in scleroderma
Toshiyuki Yamamoto
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Mechanisms of lysophosphatidic acid production
J Aoki
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Lysophosphatidic acid accelerates the development of human mast cells
S Bagga et al.
BLOOD (2004)
Targeted disruption of TGF-β/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma
G Lakos et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Lysophosphatidic acid interacts with transforming growth factor-β signaling to mediate keratinocyte growth arrest and chemotaxis
B Sauer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
The roles of Transforming growth Factor Type β3(TGF-β3) and mast cells in the pathogenesis of scleroderma
MK Ozbilgin et al.
CLINICAL RHEUMATOLOGY (2003)
Sustained activation of fibroblast transforming growth Factor-β/Smad signaling in a murine model of scleroderma
S Takagawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma
T Yamamoto et al.
CLINICAL IMMUNOLOGY (2002)
Mast cell-independent increase of type I collagen expression in experimental scleroderma induced by bleomycin
T Yamamoto et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2001)
Effect of interferon-γ on experimental scleroderma induced by bleomycin
T Yamamoto et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2000)
Share Paper
